Lodging: Analysis of the impact of COVID-19 for major lodging companies using the SWOT framework - Issue 2 (Company Impact Report)
Summary COVID-19, commonly referred to as the Coronavirus, is dominating headlines the world over. The travel & tourism sector is suffering significant disruption and the lodging industry is very much impacted.
Key Highlights - Occupancy rates around the globe are dropping rapidly. This is reflected in the steep drop in share price for most multi-national hotel companies and is currently showing no signs of recovery in the near future.
- Using the COVID-19 pandemic as a time to create positive PR or plan on future consolidation implies that many potential opportunities are progressive and will provide long term benefits.
- It is likely that the majority of hotels will be aware of their strengths and weaknesses, but opportunities and threats need to be carefully assessed in order to maximize top line growth wherever possible.
Scope - This report provides insight into what constitute strengths, weaknesses, opportunities and threats for players in the lodging industry. It also provides examples of relevant companies for each SWOT element.
Reasons to Buy - Assess the impact COVID is having on industry players
- Look at the impact coronavirus is having on share prices
- Understand what constitute strengths, weaknesses, opportunities and threats in this industry in the current climate
- Look at real-world examples of company strategies
Our reports have been used by over 10K customers, including:
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
129 pages •
By Global Industry Analysts
• Aug 2021
Abstract: The ongoing Covid-19 pandemic has highlighted the potential for mRNA therapies. The mRNA technology has experienced decades of research efforts from scientists and various biotechnology companies. Discovered in the 1960s as an option to convert DNA codes into proteins, mRNA took several decades to emerge...
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
Best foot forward: Revenue will likely rise as more healthcare providers stress the importance of preventive care Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
Stretch goals: Rising disposable incomes and an aging population will drive revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged 50 and...
Patient history: The industry will likely benefit from new-and-improved service capability advances Abstract Diagnostic & Medical Laboratories in the US Operators in the Diagnostic and Medical Laboratories industry are an integral part of patients’ medical evaluation and treatment. Laboratories are...
Strong arch: As the unemployment rate declines, the industry’s customer base will grow Abstract Eyebrow Services in the USOperators in this industry are primarily engaged in threading, waxing or otherwise servicing eyebrows. Hair and nail salons are not included in this industry. This report covers...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.